Anacor gets $22.5m from Gates for neglected diseases
This article was originally published in Scrip
Executive Summary
The Bill & Melinda Gates Foundation made a two-pronged investment totaling $22.5 million in Anacor Pharmaceuticals so that the Palo Alto, California-based company can research and develop boron compounds for at least three neglected diseases.